本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Forte BioSciences Inc

30.76
+1.103.71%
成交量:8,262.00
成交額:24.84萬
市值:3.85億
市盈率:-7.01
高:30.76
開:29.46
低:29.25
收:29.66
52周最高:31.27
52周最低:4.90
股本:1,252.69萬
流通股本:926.19萬
量比:1.23
換手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-4.3909
每股收益(LYR):-12.1671
淨資產收益率:-110.72%
總資產收益率:-58.07%
市淨率:4.58
市盈率(LYR):-2.53

資料載入中...

2023/08/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/08/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

重要事件披露

Form 8-K - Current report
2023/07/07

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/27

重要事件披露

Form 8-K - Current report
2023/05/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/31

重要事件披露

8-K - Current report
2023/03/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/09

重要事件披露

8-K - Current report
2023/01/12

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]